Usefulness of Transient and Persistent No Reflow to Predict Adverse Clinical Outcomes Following Percutaneous Coronary Intervention
- 19 December 2011
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 109 (4), 478-485
- https://doi.org/10.1016/j.amjcard.2011.09.037
Abstract
No abstract availableFunding Information
- GlaxoSmithKline
- National Health and Medical Research Council
This publication has 26 references indexed in Scilit:
- Predictive Factors and Impact of No Reflow After Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial InfarctionCirculation: Cardiovascular Interventions, 2010
- Myocardial No-Reflow in HumansJournal of the American College of Cardiology, 2009
- The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stentsAmerican Heart Journal, 2009
- Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in SwedenNew England Journal of Medicine, 2007
- Impact of Reversibility of No Reflow Phenomenon on 30-Day Mortality Following Percutaneous Revascularization for Acute Myocardial Infarction-Insights from a 1,328 Patient RegistryJournal of Interventional Cardiology, 2005
- Coronary and Myocardial AngiographyCirculation, 2004
- No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary interventionAmerican Heart Journal, 2003
- The coronary no-reflow phenomenon: a review of mechanisms and therapiesEuropean Heart Journal, 2001
- Features and outcome of no-reflow after percutaneous coronary interventionThe American Journal of Cardiology, 1995
- Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 1989